SEAGEN INC's ticker is SGEN and the CUSIP is 81181C104. A total of 491 filers reported holding SEAGEN INC in Q4 2020. The put-call ratio across all filers is 0.65 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $100,760,218 | +35.8% | 474,948 | +23.2% | 0.03% | +42.1% |
| Q2 2023 | $74,194,869 | -66.5% | 385,508 | -64.8% | 0.02% | -69.4% |
| Q1 2023 | $221,526,072 | +40.4% | 1,094,118 | -10.9% | 0.06% | +34.8% |
| Q4 2022 | $157,828,400 | -15.1% | 1,228,141 | -9.7% | 0.05% | -23.3% |
| Q3 2022 | $185,998,000 | -21.4% | 1,359,342 | +1.6% | 0.06% | -16.7% |
| Q2 2022 | $236,623,000 | -2.0% | 1,337,308 | -20.2% | 0.07% | +16.1% |
| Q1 2022 | $241,386,000 | -6.0% | 1,675,718 | +0.9% | 0.06% | 0.0% |
| Q4 2021 | $256,852,000 | -4.6% | 1,661,402 | +4.7% | 0.06% | -8.8% |
| Q3 2021 | $269,344,000 | +75.8% | 1,586,239 | +63.5% | 0.07% | +78.9% |
| Q2 2021 | $153,193,000 | +8.5% | 970,314 | -4.6% | 0.04% | 0.0% |
| Q1 2021 | $141,166,000 | -23.3% | 1,016,603 | -3.3% | 0.04% | -29.6% |
| Q4 2020 | $184,047,000 | – | 1,050,847 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 47,288,259 | $7,465,870,000 | 32.79% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 145,000 | $22,868,000 | 6.04% |
| Lagoda Investment Management, L.P. | 59,780 | $9,438,000 | 4.40% |
| Avidity Partners Management LP | 640,000 | $101,043,000 | 2.73% |
| PFM Health Sciences, LP | 482,985 | $76,254,000 | 2.39% |
| Boxer Capital, LLC | 400,000 | $63,152,000 | 2.23% |
| Redmile Group, LLC | 771,385 | $121,786,000 | 1.80% |
| Woodline Partners LP | 577,655 | $91,200,000 | 1.70% |
| Rhenman & Partners Asset Management AB | 157,925 | $24,933,000 | 1.69% |
| Parkman Healthcare Partners LLC | 45,176 | $7,132,000 | 1.56% |